COPD Subtypes Are Differentially Associated with Cardiovascular Events and COPD Exacerbations.
Chest
; 2024 Jul 31.
Article
in En
| MEDLINE
| ID: mdl-39094733
ABSTRACT
BACKGROUND:
The coronary artery calcium score (CACS) and ratio of the pulmonary artery to aorta diameters (PAA ratio) measured from chest CT scans have been established as predictors of cardiovascular events and chronic obstructive pulmonary disease (COPD) exacerbations, respectively. However, little is known about the reciprocal relationship between these predictors and outcomes. Furthermore, the prognostic implications of COPD subtypes on clinical outcomes remain insufficiently characterized. RESEARCH QUESTION How can these two chest CT-derived parameters predict subsequent cardiovascular events and COPD exacerbations in different COPD subtypes? STUDY DESIGN ANDMETHODS:
Using COPDGene study data, we assessed prospective cardiovascular disease (CVD) and COPD exacerbation risk in COPD subjects (Global Initiative for Chronic Obstructive Lung Disease spirometric grades 2-4), focusing on CACS and PAA ratio at study enrollment, with logistic regression models. These outcomes were analyzed in three COPD subtypes 1,042 Non-emphysema-predominant COPD (NEPD; low attenuation area at -950 Hounsfield units [LAA-950]<5%), 1,324 Emphysema-predominant COPD (EPD; LAA-950≥10%), and 465 Intermediate Emphysema COPD (IE; 5≤LAA-950<10%).RESULTS:
Our study indicated significantly higher overall risk for cardiovascular events in subjects with higher CACS (≥median; Odds Ratio (OR) 1.61, 95% Confidence Interval (CI)=1.30-2.00) and increased COPD exacerbations in those with higher PAA ratios (≥1; OR 1.80, 95% CI=1.46-2.23). Notably, NEPD subjects showed a stronger association between these indicators and clinical events compared to EPD (with CACS/CVD, NEPD vs. EPD, OR 2.02 vs. 1.41; with PAA ratio/COPD exacerbation, NEPD vs. EPD, OR 2.50 vs. 1.65); the difference in odds ratios between COPD subtypes was statistically significant for CACS/CVD.INTERPRETATION:
Two chest CT parameters, CACS and PAA ratio, hold distinct predictive values for cardiovascular events and COPD exacerbations that are influenced by specific COPD subtypes. TRIAL REGISTRATION ClinicalTrials.gov Identifier NCT00608764.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Chest
Year:
2024
Document type:
Article
Affiliation country:
South Korea
Country of publication:
United States